Cargando…
Erythropoietin does not activate erythropoietin receptor signaling or lipolytic pathways in human subcutaneous white adipose tissue in vivo
BACKGROUND: Erythropoietin (Epo) exerts direct effects on white adipose tissue (WAT) in mice in addition to its erythropoietic effects, and in humans Epo increases resting energy expenditure and affect serum lipid levels, but direct effects of Epo in human WAT have not been documented. We therefore...
Autores principales: | Christensen, Britt, Nellemann, Birgitte, Jørgensen, Jens Otto L., Pedersen, Steen B., Jessen, Niels |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027120/ https://www.ncbi.nlm.nih.gov/pubmed/27640183 http://dx.doi.org/10.1186/s12944-016-0327-z |
Ejemplares similares
-
No effect of 10 weeks erythropoietin treatment on lipid oxidation in healthy men
por: Risikesan, Jeyanthini, et al.
Publicado: (2020) -
Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers
por: Christensen, Britt, et al.
Publicado: (2015) -
Evaluation of Functional Erythropoietin Receptor Status in Skeletal Muscle In Vivo: Acute and Prolonged Studies in Healthy Human Subjects
por: Christensen, Britt, et al.
Publicado: (2012) -
Effects of Erythropoietin in White Adipose Tissue and Bone Microenvironment
por: Suresh, Sukanya, et al.
Publicado: (2020) -
Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012)